Filing Details
- Accession Number:
- 0001367644-20-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-21 18:12:10
- Reporting Period:
- 2020-04-17
- Accepted Time:
- 2020-04-21 18:12:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-17 | 20,414 | $26.45 | 54,670 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-17 | 20,414 | $65.00 | 34,256 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-04-20 | 17,009 | $30.86 | 51,265 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-20 | 17,009 | $69.00 | 34,256 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2020-04-17 | 20,414 | $0.00 | 20,414 | $26.45 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2020-04-20 | 17,009 | $0.00 | 17,009 | $30.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 97,393 | 2022-03-09 | No | 4 | S | Direct | |
| 80,384 | 2023-02-28 | No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- Consists of options granted under the company's stock incentive plan as amended and restated.
- The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Billionaire Hedge Funds
